Tri Locum Partners as of June 30, 2021
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 28 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Walgreen Boots Alliance (WBA) | 24.5 | $75M | 1.4M | 52.61 | |
| Regeneron Pharmaceuticals (REGN) | 13.8 | $42M | 76k | 558.54 | |
| Horizon Therapeutics Pub L SHS | 7.9 | $24M | 258k | 93.64 | |
| Medtronic SHS (MDT) | 7.5 | $23M | 185k | 124.13 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.2 | $16M | 89k | 177.64 | |
| Protagonist Therapeutics (PTGX) | 5.0 | $15M | 342k | 44.88 | |
| Johnson & Johnson (JNJ) | 4.6 | $14M | 86k | 164.74 | |
| Cigna Corp (CI) | 3.9 | $12M | 51k | 237.07 | |
| Aldeyra Therapeutics (ALDX) | 3.0 | $9.3M | 818k | 11.33 | |
| Pfizer (PFE) | 2.6 | $7.9M | 203k | 39.16 | |
| Evolus (EOLS) | 2.1 | $6.3M | 497k | 12.65 | |
| Intra Cellular Therapies (ITCI) | 2.0 | $6.2M | 151k | 40.82 | |
| Celldex Therapeutics Com New (CLDX) | 1.9 | $5.9M | 175k | 33.44 | |
| Humana (HUM) | 1.6 | $5.0M | 11k | 442.72 | |
| Edwards Lifesciences (EW) | 1.6 | $5.0M | 48k | 103.57 | |
| Endo Intl SHS Call Option | 1.6 | $4.9M | 1.0M | 4.68 | |
| Fulgent Genetics Call Option (FLGT) | 1.5 | $4.6M | 50k | 92.24 | |
| Moderna (MRNA) | 1.5 | $4.5M | 19k | 234.98 | |
| Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA) | 1.4 | $4.4M | 446k | 9.90 | |
| Eagle Pharmaceuticals (EGRX) | 1.3 | $4.1M | 95k | 42.80 | |
| Mereo Biopharma Group Ads (MREO) | 1.3 | $4.0M | 1.3M | 3.17 | |
| Lifesci Acquisition Ii Corp | 0.9 | $2.7M | 270k | 10.00 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.7 | $2.1M | 314k | 6.73 | |
| Argenx Se Sponsored Adr (ARGX) | 0.6 | $1.9M | 6.4k | 301.03 | |
| Cyclacel Pharmaceuticals | 0.6 | $1.9M | 313k | 5.92 | |
| Femasys (FEMY) | 0.5 | $1.5M | 189k | 8.11 | |
| Bellus Health Com New | 0.4 | $1.2M | 376k | 3.11 | |
| Iveric Bio | 0.2 | $611k | 97k | 6.31 |
